JENNIFER LAM, COUNSELOR
"Finding an HIV vaccine is an international effort. If we each contribute what we can, we can really make a difference across the globe."
Ongoing studies are different from Trials Enrolling Now -- enough people have already volunteered to fill all of the available spots. They're considered ongoing because we are still looking to see what kind of change happens over a given period of time. Some studies will follow participants for a year -- others will last up to four years.
It then takes time to gather and evaluate all the data, especially since most of our studies are conducted with other trial sites around the world. Once the data is finalized and conclusions are drawn, the results are published. Only then, is it considered a Completed Study.A new study for HIV-negative gay & bisexual men and transgender women (MTF). Looks to see if they can safely take tenofovir, a commonly prescribed pill used for HIV treatment.
Looks at the reasons why African Americans and Latinos decide to either participate or not participate in HIV vaccine research, and what we can do to increase their involvement.
Tests whether taking acyclovir to prevent herpes outbreaks will break the link between HIV and herpes, thereby preventing new HIV infections.
Examining how the bodies of HIV positive, long term non-progressors work to fight the disease, to see if their responses can be mimicked in drugs or vaccines to benefit others.
Investigates whether the course of HIV infection is different among those who become infected after they have received an HIV vaccine.